Climb Bio, Inc. Common Stock (CLYM) News
Latest headlines that mention CLYM, newest first · each headline opens the original publisher
- Last price
- $8.81
- Day change
- -13.54%
- Next earnings
- 2026-11-05
CLYM headlines
latest coverageBiotech stocks widely slumped Wednesday, with Rapport Therapeutics, Climb Bio and Cullinan Therapeutics among some of the hardest-hit names. The post The Biggest Losers In Biotech — And It Had Nothing To Do With 'Compelling,' 'Best-In-Disease' Data appeared first on Investor's…
Climb Bio reversed course downward Thursday despite potential "best-in-class" data for its experimental kidney disease treatment. The post Why Climb Bio, Up 1,300% Over 17 Months, Just Took A Tumble appeared first on Investor's Business Daily .
Also mentioned with CLYM
30d
Headlines that tag both tickers
CLYM news alerts
Get an alert by email or push when a new headline mentions CLYM.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.